Food naturally boosts your body’s GLP-1 levels, explained Dr. Sun Kim, an endocrinologist at Stanford Health Care in ...

With weight loss injectables like Ozempic and Mounjaro taking the world by storm, the diet industry is seemingly being left ...

"Oral GLP-1 receptor agonist Rybelsus reduces risk of cardiovascular events in type 2 diabetes patients" was originally ...

Under US law, compounding pharmacies can make and sell patent-protected drugs that are on the FDA's shortages list in limited ...

GLP-1 receptor agonists and SGLT2 inhibitors were both initially approved for type 2 diabetes. But over the last several ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

GLP-1 receptor agonists do not affect cardiovascular, kidney, or safety outcomes regardless of SGLT2 inhibitor use in patients with type 2 diabetes.

New guidelines for stroke prevention from the American Stroke Association highlight unique risk factors for women and how ...

FRANKFURT: The CEO of pharmaceuticals giant Roche, opens new tab said authorities should block the takeover of contract drug ...

The American Stroke Association has released new guidelines to lower your risk of stroke. Here’s what the organization ...

Hims & Hers is taking a more serious approach to its latest campaign. The telehealth company, which is best known for its ...